Image 1-Givlaari™ - Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

Givlaari™ (givosiran) for the Treatment of Acute Hepatic Porphyria

Image 1-Givlaari™
Givlaari™ (givosiran) is a ALAS1-directing RNAi therapeutic indicated to treat acute hepatic porphyria (AHP) in adults. Credit: Business Wire.